Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Net Margin (2018 - 2025)

Historic Net Margin for AVITA Medical (RCEL) over the last 8 years, with Q4 2025 value amounting to 12.61%.

  • AVITA Medical's Net Margin rose 1090900.0% to 12.61% in Q4 2025 from the same period last year, while for Dec 2025 it was 33.27%, marking a year-over-year increase of 784200.0%. This contributed to the annual value of 52.79% for FY2025, which is 11037700.0% up from last year.
  • According to the latest figures from Q4 2025, AVITA Medical's Net Margin is 12.61%, which was up 1090900.0% from 77.29% recorded in Q3 2025.
  • AVITA Medical's Net Margin's 5-year high stood at 12.61% during Q4 2025, with a 5-year trough of 168.03% in Q1 2024.
  • Over the past 5 years, AVITA Medical's median Net Margin value was 77.29% (recorded in 2025), while the average stood at 82.48%.
  • As far as peak fluctuations go, AVITA Medical's Net Margin surged by 3197200bps in 2021, and later plummeted by -806400bps in 2024.
  • Over the past 5 years, AVITA Medical's Net Margin (Quarter) stood at 84.73% in 2021, then skyrocketed by 31bps to 58.04% in 2022, then crashed by -100bps to 115.82% in 2023, then decreased by -5bps to 121.7% in 2024, then skyrocketed by 90bps to 12.61% in 2025.
  • Its Net Margin was 12.61% in Q4 2025, compared to 77.29% in Q3 2025 and 53.86% in Q2 2025.